Mauro Manconi,
Diego García-Borreguero
Springer New York
e druk, 2018
9781493982974
Restless Legs Syndrome/Willis Ekbom Disease
Long-Term Consequences and Management
Specificaties
Paperback, blz.
|
Engels
Springer New York |
e druk, 2018
ISBN13: 9781493982974
Rubricering
Levertijd ongeveer 8 werkdagen
Samenvatting
Due to the fact that Restless Legs Syndrome/Willis-Ekbom Disease is usually a chronic condition, this book aims to provide physicians with the necessary tools for the long-term management of patients with RLS. The first part of the book addresses the various comorbidities and long-term consequences of RLS on life quality, sleep, cognitive, psychiatric and cardiovascular systems, while the second part focuses on the management of long-term treatment and the drug-induced complications in primary RLS and in special populations. Written by experts in the field, this practical resource offers a high-quality, long-term management of RLS for neurologists, sleep clinicians, pulmonologists and other healthcare professionals.
Specificaties
ISBN13:9781493982974
Taal:Engels
Bindwijze:paperback
Uitgever:Springer New York
Inhoudsopgave
<div>I. Long Term Health Consequences of Restless Legs Syndrome/Willis-Ekbom Disease.- 1. Mental Health Disorders Associated with RLS.- 2. Sleep Impact: Insomnia, Hypersomnia, Sleep Attacks, and Circadian Disorders.- 3. Cognitive Functioning.- 4. Health Related Quality of Life and Depression/Anxiety Symptom Measures for the Assessment of Treatment in Restless Legs Syndrome/Willis-Ekbom Disease.- 5. Epidemiologic Evidence in Cardiovascular Disease.- 6. Heart Rate and Blood Pressure Changes Associated with Periodic Limb Movements.- 7. Willis-Ekbom Disease, Periodic Limb Movements of Sleep, and Cardiovascular Disease: Putative Mechanisms and Implications for Long-Term Treatment.- 8. Peripheral Muscle Changes.- 9. Outcome and Mortality in Renal Failure-Related RLS.- II. Long Term Management of Restless Legs Syndrome/Willis-Ekbom Disease.- 10. Long Term Pharmacological Treatment.- 11. Augmentation: Criteria, Prevalence, and DifferentialDiagnosis.- 12. Treatment Options When Short-Acting Dopamine Agonists Fail or Cause Augmentation: Switching or Adding Medications.- 13. Management of Augmentation.- 14. Managing Concurrent Medications.- 15. Impulsive Behaviors: Definition, Prevalence, Neurobiology, and Management.- 16. Impulse Control Behavior in Movement Disorders: Focus on Restless Leg Syndrome.- 17. Management of RLS During Pregnancy.- 18. Management of RLS in Children (Unique Features).</div><div><br></div><br>